Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Sagimet Biosciences (SGMT) Shares Outstanding (Weighted Average) (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Shares Outstanding (Weighted Average) data on record, last reported at $31.0 million in Q3 2024.

  • For Q3 2024, Shares Outstanding (Weighted Average) rose 406.17% year-over-year to $31.0 million; the TTM value through Sep 2024 reached $31.0 million, up 406.17%, while the annual FY2023 figure was $10.5 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $31.0 million in Q3 2024 per SGMT's latest filing, down from $31.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $31.9 million in Q2 2024 and bottomed at $185137.0 in Q1 2023.